chanelle animal health limited Company Information
Company Number
02598733
Next Accounts
Jan 2026
Shareholders
chanelle holdco 2
Group Structure
View All
Industry
Wholesale of pharmaceutical goods
Registered Address
483 green lanes, london, N13 4BS
Website
http://chanellegroup.iechanelle animal health limited Estimated Valuation
Pomanda estimates the enterprise value of CHANELLE ANIMAL HEALTH LIMITED at £2.3m based on a Turnover of £6.5m and 0.35x industry multiple (adjusted for size and gross margin).
chanelle animal health limited Estimated Valuation
Pomanda estimates the enterprise value of CHANELLE ANIMAL HEALTH LIMITED at £608.4k based on an EBITDA of £169k and a 3.6x industry multiple (adjusted for size and gross margin).
chanelle animal health limited Estimated Valuation
Pomanda estimates the enterprise value of CHANELLE ANIMAL HEALTH LIMITED at £2.4m based on Net Assets of £1.2m and 1.91x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Chanelle Animal Health Limited Overview
Chanelle Animal Health Limited is a live company located in london, N13 4BS with a Companies House number of 02598733. It operates in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in April 1991, it's largest shareholder is chanelle holdco 2 with a 100% stake. Chanelle Animal Health Limited is a mature, mid sized company, Pomanda has estimated its turnover at £6.5m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Chanelle Animal Health Limited Health Check
Pomanda's financial health check has awarded Chanelle Animal Health Limited a 2 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 9 areas for improvement. Company Health Check FAQs
2 Strong
1 Regular
9 Weak
Size
annual sales of £6.5m, make it smaller than the average company (£25.2m)
£6.5m - Chanelle Animal Health Limited
£25.2m - Industry AVG
Growth
3 year (CAGR) sales growth of 8%, show it is growing at a faster rate (5.2%)
- Chanelle Animal Health Limited
5.2% - Industry AVG
Production
with a gross margin of 16.9%, this company has a higher cost of product (27.6%)
16.9% - Chanelle Animal Health Limited
27.6% - Industry AVG
Profitability
an operating margin of 2.6% make it less profitable than the average company (4%)
2.6% - Chanelle Animal Health Limited
4% - Industry AVG
Employees
with 2 employees, this is below the industry average (36)
2 - Chanelle Animal Health Limited
36 - Industry AVG
Pay Structure
on an average salary of £79k, the company has an equivalent pay structure (£79k)
- Chanelle Animal Health Limited
£79k - Industry AVG
Efficiency
resulting in sales per employee of £3.3m, this is more efficient (£679.7k)
£3.3m - Chanelle Animal Health Limited
£679.7k - Industry AVG
Debtor Days
it gets paid by customers after 104 days, this is later than average (59 days)
104 days - Chanelle Animal Health Limited
59 days - Industry AVG
Creditor Days
its suppliers are paid after 12 days, this is quicker than average (29 days)
12 days - Chanelle Animal Health Limited
29 days - Industry AVG
Stock Days
it holds stock equivalent to 101 days, this is more than average (64 days)
101 days - Chanelle Animal Health Limited
64 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 6 weeks, this is less cash available to meet short term requirements (13 weeks)
6 weeks - Chanelle Animal Health Limited
13 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 78.4%, this is a higher level of debt than the average (51.7%)
78.4% - Chanelle Animal Health Limited
51.7% - Industry AVG
CHANELLE ANIMAL HEALTH LIMITED financials
Chanelle Animal Health Limited's latest turnover from April 2024 is £6.5 million and the company has net assets of £1.2 million. According to their latest financial statements, Chanelle Animal Health Limited has 2 employees and maintains cash reserves of £543.2 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 | Apr 2019 | Apr 2018 | Apr 2017 | Apr 2016 | Apr 2015 | Apr 2014 | Apr 2013 | Apr 2012 | Apr 2011 | Apr 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 6,504,257 | 4,817,278 | |||||||||||||
Other Income Or Grants | 0 | 0 | |||||||||||||
Cost Of Sales | 5,407,247 | 3,977,683 | |||||||||||||
Gross Profit | 1,097,010 | 839,595 | |||||||||||||
Admin Expenses | 928,003 | 1,003,100 | |||||||||||||
Operating Profit | 169,007 | -163,505 | |||||||||||||
Interest Payable | 854 | 0 | |||||||||||||
Interest Receivable | 0 | 7,443 | |||||||||||||
Pre-Tax Profit | 168,153 | -156,062 | |||||||||||||
Tax | -41,341 | 39,798 | |||||||||||||
Profit After Tax | 126,812 | -116,264 | |||||||||||||
Dividends Paid | 0 | 0 | |||||||||||||
Retained Profit | 126,812 | -116,264 | |||||||||||||
Employee Costs | |||||||||||||||
Number Of Employees | 2 | 4 | 4 | 4 | 4 | 4 | 3 | ||||||||
EBITDA* | 169,007 | -162,996 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 | Apr 2019 | Apr 2018 | Apr 2017 | Apr 2016 | Apr 2015 | Apr 2014 | Apr 2013 | Apr 2012 | Apr 2011 | Apr 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 0 | 0 | 509 | 541 | 584 | 640 | 753 | 1,103 | 1,487 | 1,312 | 1,749 | 2,332 | 3,109 | 4,589 | 6,202 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 0 | 0 | 509 | 541 | 584 | 640 | 753 | 1,103 | 1,487 | 1,312 | 1,749 | 2,332 | 3,109 | 4,589 | 6,202 |
Stock & work in progress | 1,501,434 | 2,676,466 | 1,142,834 | 1,149,182 | 1,859,304 | 987,895 | 749,601 | 586,203 | 673,371 | 175,160 | 138,353 | 137,384 | 115,266 | 207,497 | 126,000 |
Trade Debtors | 1,862,802 | 1,361,713 | 2,529,577 | 1,480,503 | 1,310,757 | 1,127,899 | 614,124 | 440,208 | 770,026 | 1,015,242 | 3,603,356 | 2,749,505 | 1,601,206 | 841,605 | 488,723 |
Group Debtors | 0 | 0 | 0 | 2,602,025 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 1,807,602 | 2,010,308 | 0 | 10,352 | 808,111 | 860,789 | 108,832 | 134,097 | 166,111 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash | 543,185 | 356,034 | 883,868 | 277,615 | 53,715 | 62,881 | 229,496 | 294,432 | 116,324 | 80,595 | 542,039 | 195,112 | 67,591 | 53,574 | 122,355 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 5,715,023 | 6,404,521 | 4,556,279 | 5,519,677 | 4,031,887 | 3,039,464 | 1,702,053 | 1,454,940 | 1,725,832 | 1,270,997 | 4,283,748 | 3,082,001 | 1,784,063 | 1,102,676 | 737,078 |
total assets | 5,715,023 | 6,404,521 | 4,556,788 | 5,520,218 | 4,032,471 | 3,040,104 | 1,702,806 | 1,456,043 | 1,727,319 | 1,272,309 | 4,285,497 | 3,084,333 | 1,787,172 | 1,107,265 | 743,280 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 188,330 | 399,112 | 3,330,676 | 3,925 | 41,356 | 46,792 | 87,711 | 331,712 | 726,415 | 651,502 | 3,942,972 | 3,015,118 | 1,910,773 | 1,342,571 | 963,531 |
Group/Directors Accounts | 0 | 0 | 0 | 3,848,538 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 4,290,033 | 4,895,561 | 0 | 638,455 | 2,894,236 | 1,679,410 | 499,682 | 164,093 | 190,470 | 0 | 0 | 0 | 0 | 0 | 0 |
total current liabilities | 4,478,363 | 5,294,673 | 3,330,676 | 4,490,918 | 2,935,592 | 1,726,202 | 587,393 | 495,805 | 916,885 | 651,502 | 3,942,972 | 3,015,118 | 1,910,773 | 1,342,571 | 963,531 |
loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total liabilities | 4,478,363 | 5,294,673 | 3,330,676 | 4,490,918 | 2,935,592 | 1,726,202 | 587,393 | 495,805 | 916,885 | 651,502 | 3,942,972 | 3,015,118 | 1,910,773 | 1,342,571 | 963,531 |
net assets | 1,236,660 | 1,109,848 | 1,226,112 | 1,029,300 | 1,096,879 | 1,313,902 | 1,115,413 | 960,238 | 810,434 | 620,807 | 342,525 | 69,215 | -123,601 | -235,306 | -220,251 |
total shareholders funds | 1,236,660 | 1,109,848 | 1,226,112 | 1,029,300 | 1,096,879 | 1,313,902 | 1,115,413 | 960,238 | 810,434 | 620,807 | 342,525 | 69,215 | -123,601 | -235,306 | -220,251 |
Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 | Apr 2019 | Apr 2018 | Apr 2017 | Apr 2016 | Apr 2015 | Apr 2014 | Apr 2013 | Apr 2012 | Apr 2011 | Apr 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | 169,007 | -163,505 | |||||||||||||
Depreciation | 0 | 509 | 32 | 43 | 56 | 113 | 350 | 384 | 573 | 437 | 583 | 777 | 1,233 | 1,613 | 2,080 |
Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax | -41,341 | 39,798 | |||||||||||||
Stock | -1,175,032 | 1,533,632 | -6,348 | -710,122 | 871,409 | 238,294 | 163,398 | -87,168 | 498,211 | 36,807 | 969 | 22,118 | -92,231 | 81,497 | 126,000 |
Debtors | 298,383 | 842,444 | -1,563,303 | 1,974,012 | 130,180 | 1,265,732 | 148,651 | -361,832 | -79,105 | -2,588,114 | 853,851 | 1,148,299 | 759,601 | 352,882 | 488,723 |
Creditors | -210,782 | -2,931,564 | 3,326,751 | -37,431 | -5,436 | -40,919 | -244,001 | -394,703 | 74,913 | -3,291,470 | 927,854 | 1,104,345 | 568,202 | 379,040 | 963,531 |
Accruals and Deferred Income | -605,528 | 4,895,561 | -638,455 | -2,255,781 | 1,214,826 | 1,179,728 | 335,589 | -26,377 | 190,470 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash flow from operations | 188,005 | -535,277 | |||||||||||||
Investing Activities | |||||||||||||||
capital expenditure | |||||||||||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | |||||||||||||||
Financing Activities | |||||||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | -3,848,538 | 3,848,538 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
share issue | |||||||||||||||
interest | -854 | 7,443 | |||||||||||||
cash flow from financing | -854 | 7,443 | |||||||||||||
cash and cash equivalents | |||||||||||||||
cash | 187,151 | -527,834 | 606,253 | 223,900 | -9,166 | -166,615 | -64,936 | 178,108 | 35,729 | -461,444 | 346,927 | 127,521 | 14,017 | -68,781 | 122,355 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | 187,151 | -527,834 | 606,253 | 223,900 | -9,166 | -166,615 | -64,936 | 178,108 | 35,729 | -461,444 | 346,927 | 127,521 | 14,017 | -68,781 | 122,355 |
chanelle animal health limited Credit Report and Business Information
Chanelle Animal Health Limited Competitor Analysis
Perform a competitor analysis for chanelle animal health limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other mid companies, companies in N13 area or any other competitors across 12 key performance metrics.
chanelle animal health limited Ownership
CHANELLE ANIMAL HEALTH LIMITED group structure
Chanelle Animal Health Limited has no subsidiary companies.
Ultimate parent company
CHANELLE ANIMAL HEALTH LIMITED
02598733
chanelle animal health limited directors
Chanelle Animal Health Limited currently has 3 directors. The longest serving directors include Mr Aubrey Mulveen (Apr 2024) and Ms Kara Walsh (Apr 2024).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Aubrey Mulveen | United Kingdom | 56 years | Apr 2024 | - | Director |
Ms Kara Walsh | United Kingdom | 54 years | Apr 2024 | - | Director |
Mr Angelo Gatto | United Kingdom | 51 years | Dec 2024 | - | Director |
P&L
April 2024turnover
6.5m
+35%
operating profit
169k
-203%
gross margin
16.9%
-3.23%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
April 2024net assets
1.2m
+0.11%
total assets
5.7m
-0.11%
cash
543.2k
+0.53%
net assets
Total assets minus all liabilities
chanelle animal health limited company details
company number
02598733
Type
Private limited with Share Capital
industry
46460 - Wholesale of pharmaceutical goods
incorporation date
April 1991
age
34
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
April 2024
previous names
N/A
accountant
-
auditor
-
address
483 green lanes, london, N13 4BS
Bank
-
Legal Advisor
-
chanelle animal health limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to chanelle animal health limited.
chanelle animal health limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for CHANELLE ANIMAL HEALTH LIMITED. This can take several minutes, an email will notify you when this has completed.
chanelle animal health limited Companies House Filings - See Documents
date | description | view/download |
---|